Work

Venetoclax–proteasome inhibitor–dexamethasone for unfit patients with blastic plasmacytoid dendritic cell neoplasm

Year: 2024

Type: article

Abstract: International audience

Source: Blood Advances

DOI: 10.1182/bloodadvances.2024014590

Authors: Sabine Khalife-Hachem, Arnaud Pages, Elie Akoury, Sarah Bonnet, Rudy Birsen, Clémence Busquet, Adrien Contejean, Alina Danu, Stéphane de Botton, Marie de Charette, Pierre Yves Dumas, Arnaud Jaccard, Anne Marfaing-Koka, Christophe Willekens, Eric Deconinck, David Ghez

Institutions: Institut Gustave Roussy, Inserm, Université Paris-Saclay, Centre de recherche en Epidémiologie et Santé des Populations, Centre Hospitalier Universitaire de Montpellier, Hôpital Cochin, Assistance Publique – Hôpitaux de Paris, Centre Hospitalier Universitaire de Limoges, Centre Hospitalier Annecy Genevois, Fondation Gustave Roussy, Centre Hospitalier Universitaire de La Réunion, Centre Hospitalier Universitaire de Bordeaux, Hôpital Antoine-Béclère, Centre Hospitalier Universitaire de Besançon, Université de Franche-Comté

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $3,000

OpenAlex ID: W4405100201

FWCI: 1.869

Cites: 20

Cited by: 7

Related to: 10